title: The role of palliative external beam radiation therapy in boney metastases pain management.
abstract: Bone is the third most common organ affected by neoplastic metastases, and about 70% of patients with breast cancer or prostate cancer that develop metastases will have osseous involvement. As part of a multi-pronged approach to pain management in these patients, external beam radio therapy (EBRT) continues to be a mainstay of treatment for metastatic bone pain. This article reviews the role of radiation therapy in palliative management strategies for patients with bone metastases, including the clinical and cost-effectiveness of single fraction (SFRT) versus multiple fraction (MFRT) EBRT in pain relief. Studies indicate that SFRT is more cost-effective than MFRT, yet both are clinically effective in pain management. Therefore, EBRT use retains an important place among analgesia, bone modifying agents, chemotherapy, and hormone therapy in improving quality of life (QoL) and reducing morbidity from metastatic bone pain.
authors: Pharmacotherapy Outcomes Research Center, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112-0258, USA.
authors: Beilei
authors: B
authors: Cai
authors: Nancy A
authors: NA
authors: Nickman
authors: David K
authors: DK
authors: Gaffney
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy* / Q000556:secondary / Q000601:surgery; D003362:Cost-Benefit Analysis; D006801:Humans; D059408:Pain Management / Q000191:economics / Q000379:methods*; D010166:Palliative Care / Q000191:economics / Q000379:methods*; D011788:Quality of Life; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D011878:Radiotherapy / Q000191:economics / Q000379:methods*
chemical_list: D000700:Analgesics; D050071:Bone Density Conservation Agents; D019275:Radiopharmaceuticals